Trademark: 88501693
Word

Status
Dead
Status Code
606
Status Date
Monday, December 5, 2022
Serial Number
88501693
Mark Type
2000
Filing Date
Friday, July 5, 2019
Published for Opposition
Tuesday, September 3, 2019
Abandoned Date
Monday, December 5, 2022

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
41 Educational and training services, namely, conducting classes, seminars and workshops in the field of ophthalmic diseases and disorders; providing online non-downloadable publications in the nature of articles, books and journals in the field of ophthalmic diseases and disorders and the monitoring and management of said diseases and disorders
9 Downloadable software in the nature of a mobile application for providing information relating to the treatment of ophthalmic diseases and disorders
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
35 Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services; business administration of pharmacy reimbursement programs and services; doctor's appointment reminder services pertaining to patient visits to doctors, medical centers and specialists, namely, ophthalmologists
45 Organizing and conducting support groups in the field of ophthalmology; Social networking services in the field of ophthalmological diseases and disorders and the monitoring and management of said diseases and disorders provided via a website
44 Providing medical information in the field of ophthalmic diseases and disorders; medical services, namely, assisting in the observation, monitoring, adherence and compliance of patients to medical treatments
42 Providing temporary use of a non-downloadable web application for processing patient information related to ophthalmology
The mark consists of a quadrilateral divided by a slanted line.
Color is not claimed as a feature of the mark.

Trademark Events
Dec 5, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 5, 2022
Abandonment - No Use Statement Filed
May 3, 2022
Notice Of Approval Of Extension Request E-Mailed
May 2, 2022
Sou Extension 5 Granted
Apr 25, 2022
Sou Extension 5 Filed
May 2, 2022
Case Assigned To Intent To Use Paralegal
Apr 25, 2022
Sou Teas Extension Received
Oct 26, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2021
Sou Extension 4 Granted
Oct 23, 2021
Sou Extension 4 Filed
Oct 23, 2021
Sou Teas Extension Received
Jun 14, 2021
Assigned To Examiner
Apr 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 23, 2021
Sou Extension 3 Granted
Apr 23, 2021
Sou Extension 3 Filed
Apr 23, 2021
Sou Teas Extension Received
Oct 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2020
Sou Extension 2 Granted
Oct 26, 2020
Sou Extension 2 Filed
Oct 26, 2020
Sou Teas Extension Received
Apr 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 22, 2020
Sou Extension 1 Granted
Apr 22, 2020
Sou Extension 1 Filed
Apr 22, 2020
Sou Teas Extension Received
Oct 29, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 3, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 3, 2019
Published For Opposition
Aug 14, 2019
Notification Of Notice Of Publication E-Mailed
Jul 30, 2019
Assigned To Lie
Jul 20, 2019
Approved For Pub - Principal Register
Jul 19, 2019
Examiner's Amendment Entered
Jul 19, 2019
Notification Of Examiners Amendment E-Mailed
Jul 19, 2019
Examiners Amendment E-Mailed
Jul 19, 2019
Examiners Amendment -Written
Jul 18, 2019
Assigned To Examiner
Jul 16, 2019
Notice Of Design Search Code E-Mailed
Jul 15, 2019
New Application Office Supplied Data Entered
Jul 9, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24